Is The Non-compete Clause For Cross-border Deals In India A Burden Or A Boost?
This article was originally published in PharmAsia News
Executive Summary
Deal makers are cautiously viewing the fallout of a recent government statute to prevent non-compete clauses in cross-border deals for existing Indian companies except in special circumstances. Experts await clarification on the statute but some say the new norm will impede deals and affect valuations.